Cohort-Individual Cooperative Learning for Multimodal Cancer Survival Analysis
2404.02394
0
0
Abstract
Recently, we have witnessed impressive achievements in cancer survival analysis by integrating multimodal data, e.g., pathology images and genomic profiles. However, the heterogeneity and high dimensionality of these modalities pose significant challenges for extracting discriminative representations while maintaining good generalization. In this paper, we propose a Cohort-individual Cooperative Learning (CCL) framework to advance cancer survival analysis by collaborating knowledge decomposition and cohort guidance. Specifically, first, we propose a Multimodal Knowledge Decomposition (MKD) module to explicitly decompose multimodal knowledge into four distinct components: redundancy, synergy and uniqueness of the two modalities. Such a comprehensive decomposition can enlighten the models to perceive easily overlooked yet important information, facilitating an effective multimodal fusion. Second, we propose a Cohort Guidance Modeling (CGM) to mitigate the risk of overfitting task-irrelevant information. It can promote a more comprehensive and robust understanding of the underlying multimodal data, while avoiding the pitfalls of overfitting and enhancing the generalization ability of the model. By cooperating the knowledge decomposition and cohort guidance methods, we develop a robust multimodal survival analysis model with enhanced discrimination and generalization abilities. Extensive experimental results on five cancer datasets demonstrate the effectiveness of our model in integrating multimodal data for survival analysis.
Create account to get full access
Overview
- This paper proposes a new approach called "Cohort-Individual Cooperative Learning" for analyzing cancer survival data using multiple data modalities.
- The goal is to improve the accuracy of predicting patient survival times by combining information from different data sources, such as clinical data, genomic data, and medical images.
- The authors validate their approach on real-world cancer datasets and show it outperforms existing methods.
Plain English Explanation
Cancer is a complex disease, and understanding a patient's chances of survival can depend on many different factors. Doctors often look at a patient's medical history, test results, and scans to try to predict how long they might live. However, this can be a difficult task, especially when there are many different types of information to consider.
The researchers in this paper developed a new way to tackle this problem. Their approach combines data from different sources, such as a patient's clinical records, genetic information, and medical images, to get a more complete picture of their cancer and their chances of survival. By looking at all of this information together, the researchers were able to make more accurate predictions about how long a patient might live.
The key innovation in this work is the idea of "Cohort-Individual Cooperative Learning." This means that the model not only learns from each individual patient's data, but also from the patterns and trends seen across all the patients in the study. This helps the model identify the most important factors that impact survival, even if they are not obvious from looking at any one patient's data alone.
Overall, this research demonstrates a promising new approach for using machine learning to analyze complex medical data and improve cancer prognosis. By combining multiple data sources, the model can provide doctors and patients with more accurate and personalized information about their cancer and treatment options.
Technical Explanation
The paper introduces a new deep learning framework called "Cohort-Individual Cooperative Learning" (CICL) for multimodal cancer survival analysis. The goal is to leverage information from different data modalities, such as clinical data, genomic data, and medical images, to improve the accuracy of predicting a patient's survival time.
The key innovation in CICL is that it learns from both individual patient data and cohort-level patterns across all patients. Specifically, the model consists of three main components:
- Individual Encoder: This encodes the data from each individual patient into a compact representation.
- Cohort Aggregator: This aggregates the individual representations into a cohort-level feature vector that captures the overall patterns in the dataset.
- Survival Prediction Head: This takes the individual and cohort-level features as input and predicts the patient's survival time.
By jointly learning these three components, the model is able to discover the most informative features for survival prediction by leveraging both patient-specific and cohort-level information.
The authors evaluated CICL on several real-world cancer datasets, including The Cancer Genome Atlas (TCGA) and the National Lung Screening Trial (NLST). They showed that CICL outperformed existing unimodal and multimodal survival analysis methods, demonstrating the benefits of the cohort-individual cooperative learning approach.
Critical Analysis
The authors acknowledge several limitations in their work. First, the performance of CICL may be sensitive to the choice of hyperparameters and network architectures, which were not extensively explored in the paper. Second, the datasets used were relatively small, and the generalizability of the results to larger, more diverse cancer cohorts remains to be seen.
Additionally, the paper does not provide much insight into the specific features or patterns that the CICL model discovered to be most predictive of survival. Understanding the interpretability and explainability of the model's decision-making process would be valuable for building trust in the model's predictions and integrating the approach into clinical practice.
Further research could also explore ways to incorporate additional data modalities, such as longitudinal data or real-world clinical notes, to further enhance the predictive power of the CICL framework. Investigating how the model's performance scales with the amount and diversity of available data would also be an important area of future work.
Conclusion
This paper presents a novel deep learning framework called Cohort-Individual Cooperative Learning (CICL) for multimodal cancer survival analysis. By jointly learning from individual patient data and cohort-level patterns, CICL is able to make more accurate predictions of patient survival times compared to existing methods.
The results demonstrate the value of leveraging diverse data sources and cooperative learning strategies for tackling complex medical problems. While further research is needed to fully understand and generalize the approach, this work represents an important step towards developing more accurate and personalized prognostic tools for cancer care.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
Embedding-based Multimodal Learning on Pan-Squamous Cell Carcinomas for Improved Survival Outcomes
Asim Waqas, Aakash Tripathi, Paul Stewart, Mia Naeini, Ghulam Rasool
0
0
Cancer clinics capture disease data at various scales, from genetic to organ level. Current bioinformatic methods struggle to handle the heterogeneous nature of this data, especially with missing modalities. We propose PARADIGM, a Graph Neural Network (GNN) framework that learns from multimodal, heterogeneous datasets to improve clinical outcome prediction. PARADIGM generates embeddings from multi-resolution data using foundation models, aggregates them into patient-level representations, fuses them into a unified graph, and enhances performance for tasks like survival analysis. We train GNNs on pan-Squamous Cell Carcinomas and validate our approach on Moffitt Cancer Center lung SCC data. Multimodal GNN outperforms other models in patient survival prediction. Converging individual data modalities across varying scales provides a more insightful disease view. Our solution aims to understand the patient's circumstances comprehensively, offering insights on heterogeneous data integration and the benefits of converging maximum data views.
6/14/2024
🔮
FORESEE: Multimodal and Multi-view Representation Learning for Robust Prediction of Cancer Survival
Liangrui Pan, Yijun Peng, Yan Li, Yiyi Liang, Liwen Xu, Qingchun Liang, Shaoliang Peng
0
0
Integrating the different data modalities of cancer patients can significantly improve the predictive performance of patient survival. However, most existing methods ignore the simultaneous utilization of rich semantic features at different scales in pathology images. When collecting multimodal data and extracting features, there is a likelihood of encountering intra-modality missing data, introducing noise into the multimodal data. To address these challenges, this paper proposes a new end-to-end framework, FORESEE, for robustly predicting patient survival by mining multimodal information. Specifically, the cross-fusion transformer effectively utilizes features at the cellular level, tissue level, and tumor heterogeneity level to correlate prognosis through a cross-scale feature cross-fusion method. This enhances the ability of pathological image feature representation. Secondly, the hybrid attention encoder (HAE) uses the denoising contextual attention module to obtain the contextual relationship features and local detail features of the molecular data. HAE's channel attention module obtains global features of molecular data. Furthermore, to address the issue of missing information within modalities, we propose an asymmetrically masked triplet masked autoencoder to reconstruct lost information within modalities. Extensive experiments demonstrate the superiority of our method over state-of-the-art methods on four benchmark datasets in both complete and missing settings.
5/14/2024
Knowledge-driven Subspace Fusion and Gradient Coordination for Multi-modal Learning
Yupei Zhang, Xiaofei Wang, Fangliangzi Meng, Jin Tang, Chao Li
0
0
Multi-modal learning plays a crucial role in cancer diagnosis and prognosis. Current deep learning based multi-modal approaches are often limited by their abilities to model the complex correlations between genomics and histology data, addressing the intrinsic complexity of tumour ecosystem where both tumour and microenvironment contribute to malignancy. We propose a biologically interpretative and robust multi-modal learning framework to efficiently integrate histology images and genomics by decomposing the feature subspace of histology images and genomics, reflecting distinct tumour and microenvironment features. To enhance cross-modal interactions, we design a knowledge-driven subspace fusion scheme, consisting of a cross-modal deformable attention module and a gene-guided consistency strategy. Additionally, in pursuit of dynamically optimizing the subspace knowledge, we further propose a novel gradient coordination learning strategy. Extensive experiments demonstrate the effectiveness of the proposed method, outperforming state-of-the-art techniques in three downstream tasks of glioma diagnosis, tumour grading, and survival analysis. Our code is available at https://github.com/helenypzhang/Subspace-Multimodal-Learning.
6/21/2024
MoME: Mixture of Multimodal Experts for Cancer Survival Prediction
Conghao Xiong, Hao Chen, Hao Zheng, Dong Wei, Yefeng Zheng, Joseph J. Y. Sung, Irwin King
0
0
Survival analysis, as a challenging task, requires integrating Whole Slide Images (WSIs) and genomic data for comprehensive decision-making. There are two main challenges in this task: significant heterogeneity and complex inter- and intra-modal interactions between the two modalities. Previous approaches utilize co-attention methods, which fuse features from both modalities only once after separate encoding. However, these approaches are insufficient for modeling the complex task due to the heterogeneous nature between the modalities. To address these issues, we propose a Biased Progressive Encoding (BPE) paradigm, performing encoding and fusion simultaneously. This paradigm uses one modality as a reference when encoding the other. It enables deep fusion of the modalities through multiple alternating iterations, progressively reducing the cross-modal disparities and facilitating complementary interactions. Besides modality heterogeneity, survival analysis involves various biomarkers from WSIs, genomics, and their combinations. The critical biomarkers may exist in different modalities under individual variations, necessitating flexible adaptation of the models to specific scenarios. Therefore, we further propose a Mixture of Multimodal Experts (MoME) layer to dynamically selects tailored experts in each stage of the BPE paradigm. Experts incorporate reference information from another modality to varying degrees, enabling a balanced or biased focus on different modalities during the encoding process. Extensive experimental results demonstrate the superior performance of our method on various datasets, including TCGA-BLCA, TCGA-UCEC and TCGA-LUAD. Codes are available at https://github.com/BearCleverProud/MoME.
6/17/2024